GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

A person wears the G7 (on the left arm) and t:slim X2 (on the waist). [Image courtesy of Tandem Diabetes Care] It’s been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn’t ...

The Glucotrack implantable CBGM next to three U.S. quarters to demonstrate its size. [Image courtesy of Glucotrack] Glucotrack (Nasdaq:GCTK) believes it can tap into a diabetes market that includes ...

The t:slim X2 system (left) and FreeStyle Libre 3 (right). [Images courtesy of Tandem Diabetes Care and Abbott] Tandem Diabetes Care (Nasdaq:TNDM) announced today that its t:slim X2 system now works ...

The G7 CGM now connects directly to the Apple Watch. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S. The ...

According to Medtronic, the ADA’s 2025 standards of care now endorse the use of automated insulin delivery for adults with insulin-intensive type 2 diabetes. Medtronic’s system remains investigational ...

[Image from Ypsomed] Ypsomed and CamDiab announced today that they agreed to integrate their mylife Loop automated insulin delivery system with a future Abbott (NYSE:ABT) sensor. The companies plan to ...

Oura and Stelo alongside the mobile app. [Image courtesy of Dexcom/Oura] As one of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

The t:slim X2 automated insulin delivery system with the Dexcom G6. [Image from Tandem Diabetes Care] A new study showed improved glucose control in pregnant women using Tandem Diabetes Care ...